Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 24746576.
- Also identified by DOI 10.1016/j.radonc.2014.03.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial DNA common variants have been reported to be associated with the development of radiation-induced toxicity. Using a large cohort of patients, we aimed to validate these findings by investigating the potential role of common European mitochondrial DNA SNPs (mtSNPs) to the development of radio-toxicity. Overall acute and late toxicity data were assessed in a cohort of 606 prostate cancer patients by means of Standardized Total Average Toxicity (STAT) score. We carried out association tests between radiation toxicity and a selection of 15 mtSNPs (and the haplogroups defined by them). Statistically significant association between mtSNPs and haplogroups with toxicity could not be validated in our Spanish cohort. The present study suggests that the mtDNA common variants analyzed are not associated with clinically relevant increases in risk of overall radiation-induced toxicity in prostate cancer patients.
Medical subject headings
- DNA, Mitochondrial
- Genetic Predisposition to Disease
- Genetic Variation
- Prostatic Neoplasms
- Radiation Injuries
- Radiotherapy, Conformal